Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery - Related Studies

Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery

This study is ongoing, but not recruiting participants.

Study NCT00101075. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Head and Neck Cancer

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Salivary Gland Diseases
		Salivary Gland Neoplasms

3	More general conditions related to this trial
		Mouth Diseases
		Mouth Neoplasms
		Neoplasms
		Neoplasms by Site
		Stomatognathic Diseases

4	Interventions listed in this trial
		capecitabine
		oxaliplatin

5	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Dana-Farber Cancer Institute
		National Cancer Institute (NCI)